Clinical Trial Update: Maintenance of Remission With Rituximab Versus Azathioprine for Newly-diagnosed or Relapsing Eosinophilic Granulomatosis With Polyangiitis. [Phase 3]

View source ↗

Summary

Phase 3 trial comparing rituximab to azathioprine for maintaining remission in eosinophilic granulomatosis with polyangiitis (EGPA) has completed, evaluating wh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Granulomatosis with Polyangiitis

Drugs mentioned

• Azathioprine (azathioprine)
• Rituxan (rituximab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Eosinophilic Granulomatosis With Polyangiitis | Phase 3 | Status: COMPLETED